NCT06932809View on ClinicalTrials.gov

Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

May 9, 2025

Primary Completion Date

April 30, 2030

Study Completion Date

April 30, 2030

Conditions
Tauopathies
Interventions
DRUG

18F-JSS20-183A PET

2 hour Positron Emission Tomography (PET) scan using new radiotracer 18F-JSS20-183A.

DIAGNOSTIC_TEST

Brain MRI

MRI scan of the brain.

DIAGNOSTIC_TEST

Amyloid PET

PET scan with Florbetaben F18 or 11C-PiB.

BEHAVIORAL

Neurological Assessments

Neurological assessments, including a video interview.

Trial Locations (1)

19104

RECRUITING

University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER